Although the results of this study suggest that NKCC1 antagonism might improve disorders where conditioned anxiety plays an important role, such as PTSD, and not disorders marked by unconditioned anxiety, such as GAD, the available literature suggests that this may not be the case (see Table 3). The gene discussed is SLC12A2; the disease is generalized anxiety disorder.